Liverpool, United Kingdom
TTS Pharma Ltd, founded in 2012 and headquartered in the United Kingdom, is a pioneering force in the biopharma, biotechnology, healthcare, and pharmaceutical industries, with a sharp focus on medicinal cannabis and wellness solutions. The company's mission, as expressed in its slogan, "TTS Pharma | Advancing Innovation in Medicinal Cannabis & Wellness Solutions 🌿💡," emphasizes its commitment to innovation and scientific excellence.
The company has established a comprehensive value chain from cultivation and extraction to formulation and distribution, ensuring the delivery of high-quality, consistent, and safe cannabinoid-based products. By collaborating with regulators, medical professionals, and industry leaders, TTS Pharma positions itself at the forefront of cannabinoid-based healthcare advancements.
In its Series B round on 01 May 2019, TTS Pharma received a substantial investment of £10.30M, reflecting strong investor confidence in its potential to drive progress in this burgeoning sector.
